Inventiva (IVA) Accounts Payables (2018 - 2025)
Inventiva (IVA) posted quarterly Accounts Payables of $30.3 million for Q4 2025, down 13.76% year-over-year from $35.1 million in Q4 2024, and down 99.92% quarter-over-quarter from $39.3 billion in Q2 2025.
Inventiva (IVA) Accounts Payables (2018 - 2025) Analysis & Trends
Inventiva's Accounts Payables history runs 8 years deep, the most recent figure standing at $30.3 million for Q4 2025.
- In Q4 2025, Accounts Payables fell 13.76% year-over-year to $30.3 million; the TTM figure through Dec 2025 stood at $30.3 million (down 13.76% YoY), while the FY2025 annual figure was $30.3 million, down 13.76% from the prior year.
- Accounts Payables for Q4 2025 stood at $30.3 million, down from $39.3 billion in the prior quarter.
- The five-year high for Accounts Payables was $39.3 billion in Q2 2025, with the low at $10.4 million in Q4 2023.
- The 5-year median for Accounts Payables is $30.8 million (2023), against an average of $4.6 billion.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables surged 123896.19% in 2022, then plunged 99.79% in 2023.
- Inventiva's Accounts Payables stood at $16.7 million in 2021, then increased by 18.24% to $19.8 million in 2022, then surged by 105.26% to $40.5 million in 2023, then declined by 13.38% to $35.1 million in 2024, then decreased by 13.76% to $30.3 million in 2025.
- Business Quant data shows IVA's Accounts Payables at $30.3 million in Q4 2025, $39.3 billion in Q2 2025, and $35.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | 30.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.28 Mn |
| Jun 30, 2025 | 39.28 Bn |
| Dec 31, 2024 | 35.12 Mn |
| Jun 30, 2024 | 40.58 Mn |
| Dec 31, 2023 | 40.54 Mn |
| Oct 11, 2023 | 10.40 Mn |
| Jun 30, 2023 | 31.24 Mn |
| Dec 31, 2022 | 19.75 Mn |
| Jun 30, 2022 | 15.21 Bn |
| Dec 31, 2021 | 16.70 Mn |
| Jun 30, 2021 | 12.27 Mn |
| Mar 31, 2021 | 10.48 Mn |
| Dec 31, 2020 | 8.25 Mn |
| Jun 30, 2020 | 9.39 Mn |
| Dec 31, 2019 | 8.29 Mn |
| Dec 31, 2018 | 9.56 Mn |